{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:32Z","timestamp":1753890632691,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the distribution and antibiotic resistance of pathogens in patients with Type 2 Diabetes Mellitus (T2DM) complicated by Urinary Tract Infections (UTIs), and to explore the value of serum Procalcitonin (PCT) level alterations in the diagnosis and assessment of disease severity in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective analysis included 100 patients with T2DM complicated by UTIs admitted to the Sixth Affiliated Hospital of Kunming Medical University between January 2021 and August 2024, who constituted the Infection group. A control group, the T2DM group, consisted of 100 patients with T2DM without UTIs. Key demographic data were retrospectively analyzed and evaluated. Bacterial isolation and identification, along with antimicrobial susceptibility testing using an automated analyzer, were performed to determine the distribution and antimicrobial resistance profiles of the isolated pathogens. Serum PCT levels were measured using electrochemiluminescence immunoassay. Receiver Operating Characteristic (ROC) curve analysis was used to evaluate the diagnostic value of PCT for T2DM complicated by UTIs. The optimal cutoff value was calculated using the Youden index derived from the ROC curve.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>146 pathogenic strains were isolated from the 200 submitted specimens. Gram-negative bacteria accounted for 66.44% (n=97), Gram-positive bacteria for 14.38% (n=21), and fungi for 19.18% (n=28). <jats:italic>Escherichia coli<\/jats:italic> was the most common pathogen. Antimicrobial susceptibility testing revealed high resistance rates of <jats:italic>E. coli<\/jats:italic> to levofloxacin and ampicillin, while no resistance was observed to amikacin and tigecycline. <jats:italic>Candida glabrata<\/jats:italic> exhibited high resistance to itraconazole, but no resistance to 5-flucytosine, fluconazole, or voriconazole. Serum PCT levels were significantly elevated in the infection group compared to the T2DM group (P&amp;lt; 0.05). ROC curve analysis revealed that the area under the curve (AUC) for PCT in diagnosing T2DM complicated by UTIs was 0.700 (95% CI, 0.628-0.772). The maximum Youden index was calculated to be 0.36, corresponding to an optimal cutoff value of 0.0965 ng\/L on the ROC curve.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>Escherichia coli<\/jats:italic> and <jats:italic>Candida glabrata<\/jats:italic> are the predominant pathogens in T2DM patients with UTIs. Serum PCT levels have moderate value in the diagnosis of patients with T2DM complicated by UTIs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1609966","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:12:53Z","timestamp":1748491973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of pathogen distribution and serum procalcitonin level alterations in patients with type 2 diabetes mellitus complicated by urinary tract infections"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuan","family":"Pu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1172\/jci142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"131","author":"Taylor","year":"2021","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"Bmj"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/medicina59101747","article-title":"Particularities of urinary tract infections in diabetic patients: A concise review","volume":"59","author":"Confederat","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.727008","article-title":"Type 2 innate lymphoid cells: protectors in type 2 diabetes","volume":"12","author":"Painter","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1056\/NEJMp2308230","article-title":"Type 2 diabetes - controlling the epidemic, episode 1: understanding and preventing type 2 diabetes","volume":"389","author":"Abel","year":"2023","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40001-022-00644-9","article-title":"The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis","volume":"27","author":"Salari","year":"2022","journal-title":"Eur J Med Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-139090","article-title":"Symptoms, risk factors, diagnosis and treatment of urinary tract infections","volume":"97","author":"Kaur","year":"2021","journal-title":"Postgrad Med J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01169-z","article-title":"Diagnostic utility of procalcitonin for bacterial infections in diabetic ketoacidosis","volume":"23","author":"Pannu","year":"2023","journal-title":"Clin Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.10.015","article-title":"The predictive value of procalcitonin for early detection of infection in elderly type 2 diabetes mellitus","volume":"26","author":"Lin","year":"2020","journal-title":"J\u00a0Infect Chemother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04417-1","article-title":"Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections","author":"Lin","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2444495","DOI":"10.1001\/jamanetworkopen.2024.44495","article-title":"Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: A wikiGuidelines group consensus statement","volume":"7","author":"Nelson","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1574-6976.2011.00298.x","article-title":"Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology","volume":"36","author":"Croxatto","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2017_21","article-title":"Urinary tract infection and Diabetes Mellitus-Etio-clinical profile and antibiogram: A North Indian perspective","volume":"11","author":"Jagadeesan","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12933-021-01213-w","article-title":"Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-020-01818-x","article-title":"Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies","volume":"202","author":"Akash","year":"2020","journal-title":"Arch Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.32592\/ari.2024.79.1.92","article-title":"Effect of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in patients with urinary tract infection","volume":"79","author":"Shahsavari","year":"2024","journal-title":"Arch Razi Inst"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2017.08.003","article-title":"Antimicrobial resistance in women with urinary tract infection in primary care: No relation with type 2 diabetes mellitus","volume":"12","author":"Vinken","year":"2018","journal-title":"Prim Care Diabetes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0166022","DOI":"10.1128\/spectrum.01660-22","article-title":"Characteristics of escherichia coli urine isolates and risk factors for secondary bloodstream infections in patients with urinary tract infections","volume":"10","author":"Choi","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/antibiotics13121218","article-title":"Prevalence of antimicrobial resistance among the WHO's AWaRe classified antibiotics used to treat urinary tract infections in diabetic women","volume":"13","author":"Hamdan","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e55556","DOI":"10.7759\/cureus.55556","article-title":"Molecular characterization of escherichia coli causing urinary tract infections through next-generation sequencing: A comprehensive analysis of serotypes, sequence types, and antimicrobial and virulence genes","volume":"16","author":"Kandi","year":"2024","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0098623","DOI":"10.1128\/aac.00986-23","article-title":"Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022","volume":"67","author":"D\u00edaz-Garc\u00eda","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2021.1988047","article-title":"Clinical utility of procalcitonin and its association with pathogenic microorganisms","volume":"59","author":"Hua-Guo","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24154","article-title":"Elevated procalcitonin levels in a patient with diabetic ketoacidosis in the absence of infection","volume":"14","author":"Basheer","year":"2022","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17164","DOI":"10.1038\/s41598-023-44451-6","article-title":"Correlation of procalcitonin and c-reactive protein levels with pathogen distribution and infection localization in urinary tract infections","volume":"13","author":"Shi","year":"2023","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ebch.1927","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"8","author":"Schuetz","year":"2013","journal-title":"Evid Based Child Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.13174","article-title":"Update of biomarkers to diagnose diabetic foot osteomyelitis: A meta-analysis and systematic review","volume":"32","author":"Ansert","year":"2024","journal-title":"Wound Repair Regener"},{"key":"B30","doi-asserted-by":"publisher","first-page":"Itc65","DOI":"10.7326\/aitc201911050","article-title":"Type 2 diabetes","volume":"171","author":"Vijan","year":"2019","journal-title":"Ann Intern Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1551871","article-title":"The etiology and management of recurrent urinary tract infections in postmenopausal women","volume":"22","author":"Jung","year":"2019","journal-title":"Climacteric"},{"key":"B32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12879-023-08711-0","article-title":"elderly hospitalized patients with catheter-associated urinary tract infection: a case-control study","volume":"23","author":"Shen","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0303557","DOI":"10.1371\/journal.pone.0303557","article-title":"Sepsis risk in diabetic patients with urinary tract infection","volume":"19","author":"Wang","year":"2024","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0310903","DOI":"10.1371\/journal.pone.0310903","article-title":"Risk factors for urinary tract infection in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis","volume":"19","author":"Jia","year":"2024","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1609966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:12:54Z","timestamp":1748491974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1609966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":34,"alternative-id":["10.3389\/fendo.2025.1609966"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1609966","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1609966"}}